UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 20, 2009
(Exact Name of Registrant as Specified in Charter)
| | | | |
Delaware | | 001- 33707 | | 04-3285398 |
|
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | |
Reservoir Place | | |
1601 Trapelo Road, Suite 329 | | |
Waltham, Massachusetts | | 02451 |
|
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (781) 472-8100
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events
From August 20, 2009 to September 4, 2009, while it was permissible under the applicable securities laws for officers of Constant Contact, Inc. (the “Company”) to purchase and sell securities of the Company, the following officers entered into binding trading plans (the “10b5-1 Plans”):
| | | | | | |
| | | | Maximum number | | |
| | | | of shares of | | |
| | | | common stock that | | Time period during |
| | | | may be sold under | | which sales may occur |
Name | | Title | | the 10b5-1 Plans | | under the 10b5-1 Plans |
| | | | | | |
Gail F. Goodman | | Chairman, President and | | | | |
| | Chief Executive Officer | | 100,000 | | 12/1/2009 — 11/30/2010 |
| | | | | | |
Nancie Freitas | | Vice President and | | | | |
| | Chief Marketing Officer | | 10,400 | | 12/15/2009 — 5/15/2010 |
Pursuant to the 10b5-1 Plans, certain shares of the Company’s common stock held by such officers will be sold on a periodic basis without further direction from the officer in accordance with the terms and conditions set forth in the applicable 10b5-1 Plan, which in all cases include minimum sale price thresholds. Under the Company’s insider trading policy, trades will not occur under the 10b5-1 Plans until at least 90 days after the execution date of the applicable 10b5-1 Plan.
Each of the 10b5-1 Plans is designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, and the Company’s insider trading policy. Transactions made pursuant to the 10b5-1 Plans will be disclosed publicly through Form 144 and Form 4 filings with the Securities and Exchange Commission.
In addition, on August 20, 2009, Michael T. Fitzgerald, a director of the Company, amended his existing trading plan under Rule 10b5-1, which he entered into in March 2009, to increase the number of shares of common stock that may be sold under the plan from 60,000 to 90,000 and to extend the termination date of the plan from December 19, 2009 to December 31, 2009. In accordance with the Company’s insider trading policy, the amendment will not be effective until November 20, 2009. Through the date of this Current Report on Form 8-K, Mr. Fitzgerald has sold 33,000 shares of common stock under the plan.
Except as may be required by law, the Company does not undertake to report on specific Rule 10b5-1 plans of the Company’s officers or directors, nor to report modifications or terminations of such plans.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
| CONSTANT CONTACT, INC. | |
Date: September 8, 2009 | By: | /s/ Robert P. Nault | |
| | Robert P. Nault | |
| | Vice President and General Counsel | |
|